ArticlePharmacoEconomics - open2023

Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain.

A M Alonso Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.